Cryogenic OGS

Q4 FY27 Earnings Call Analysis

Industrial Manufacturing

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 2margin: Category 3orderbook: Yes
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- Current order book/post sales: Approximately ₹22 to ₹25 crore. - Bids submitted: Around ₹65 crore as of the date. - Expectation for the second half of FY26: Similar growth to the first half. - Significant ongoing projects: 143 truck loading skids for Egypt and a metering skid project for Honeywell Nigeria. - Visibility on future orders: Expecting good orders of similar size in the first half of FY27 and throughout FY27. - Additional bids and tenders: Received many new orders for density probes and quoted for different locations under tendering. - Target markets: Both domestic and global markets are being pursued actively.
💰

fundraise

Any current/future new fundraising through debt or equity?

- Cryogenic OGS Limited is a zero-debt company and has maintained strict financial discipline and balance sheet strength for the past 4 to 5 years. - There is no mention of any current or planned fundraising through debt or equity during the event. - The company recently raised funds through IPO to support working capital needs for transitioning from assembler/fabricator to system integrator. - They are planning capital expenditure for a new facility within the next 2 years but have not indicated raising fresh capital for this yet. - Existing working capital cash on hand is sufficient for current procurement and project requirements. - Overall, no explicit plans for new debt or equity fundraising were disclosed in this event.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- The company is slowly building a new facility, anticipating a need for capex within two years. - The new facility development has begun step by step, with early preparations already underway. - Current capacity utilization is about 35-40%; significant capex for a new facility is expected after reaching 75 to 100 crores revenue. - Past capex done in FY17, FY20, and FY21 improved gross margins; further expansion is planned for 2-3 years down the line. - The management expects scope to improve gross margins through higher value addition, new product certifications, and international market expansion. - Strategic investments target new technologies in LNG and green hydrogen product capabilities and metering technologies. - Planning to scale from a domestic engineering base to a global, integrated, high-margin solutions platform.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Expecting similar growth in the second half of FY26 as in the first half. - Order book currently around ₹22-25 crores with ₹65 crores in bids submitted. - Facility capacity can support up to double the current revenue without major capex. Significant capex expected only after reaching ₹75-100 crores revenue. - Aggressively targeting domestic and global markets, including expansion into LNG and green hydrogen product capabilities. - Anticipate repeat and new orders internationally, e.g., large orders in Egypt and Nigeria, and inquiries from Middle East customers. - Focus on scaling from domestic engineering base to global integrated solutions platform. - Growth driven by new technologies like the density probe with increasing orders post initial success. - Goal to improve gross margins via margin maximization on bought-out products, new products, and international customers with better margins.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Cryogenic OGS is aggressively targeting growth over the next 2-3 years, focusing on new technologies and international markets. - They plan to scale from a strong domestic base to a global, integrated, high-margin solutions platform. - Expectation to maintain or improve EBITDA margins around 30% and gross margins around 20% going forward. - Growth drivers include expansion in LNG, green hydrogen capabilities, metering technologies, and international orders. - The company is transitioning from assembler/fabricator to full systems integrator, enabling higher value addition and better margins. - Order book and bid pipeline remain strong with over ₹22-25 crores in confirmed orders and ₹65 crores in bids. - Capacity utilization is at 35-40%, allowing 50-100% revenue growth without immediate major Capex. - New facility development is underway, anticipating capacity expansion in 2-3 years to support further revenue growth.